Cannabis News

Medical Marijuana, Inc. Subsidiary Kannaway® Opens New Office and Warehouse in Johannesburg, South Africa


SAN DIEGO, 01 Feb. 2022 (GLOBE NEWSWIRE) — via NewMediaWireMedical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chains, announced today today that its subsidiary Kannaway® opened a new office and warehouse in South Africa.

The new 3,326 square foot combined facility is located just east of Johannesburg, making it easy for employees and visitors to access. The facility allows Kannaway® to ship the company’s full line of products nationwide.

“Our strategic decision to make South Africa a top priority for the company’s international growth this year comes with big ideas and even bigger execution,” said Kannaway® CEO Blake Schroeder. . “This new warehouse will allow us to reach more customers in the region and reduce our operating costs.”

Recent reports Department of Agriculture, Land Reform and Rural Development report that the South African cannabidiol (CBD) market is currently valued at around $1.9 billion and could create more than 25,000 jobs.

“This new office and warehouse is just our first step towards greater expansion across Africa,” said Duduzile Mathole, Country Manager for Kannaway®, South Africa.

To learn more about Kannaway®, please visit the company online at https://www.kannaway.com/.

About Kannaway®
Kannaway® is a network sales and marketing company specializing in the sale and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, providing unique insight and opportunity for sales professionals who want to become successful leaders in the sale and marketing of botanicals. of hemp.

About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct non-psychoactive cannabinoid business units: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in providing the highest quality non-psychoactive legal cannabis products derived from industrial hemp; and a clinical research and development sector for cannabinoid-based botanical drugs led by its pharmaceutical investment companies and partners, including AXIM® Biotechnologies, Inc.. and Neuropathix. Medical Marijuana, Inc. was named one of the top CBD producers by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in developing international markets. The company’s flagship product Genuine Scientific Hemp Oil has been used in several successful clinical studies in Mexico and Brazil to understand its safety and effectiveness.

Medical Marijuana, Inc. is headquartered in San Diego, CA and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To view the Medical Marijuana, Inc. corporate video, Click here.

PROSPECTIVE DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by these articles. This document contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. These forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to differ materially from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute products that violate the US Controlled Substances Act.

CONTACT:
Public relations contact:
Katherine Brown
Account director
CMW Media
858-264-6600
[email protected]
www.cmwmedia.com

Contact with Investor Relations:
T. (858) 283-4016
[email protected]



#Medical #Marijuana #Subsidiary #Kannaway #Opens #Office #Warehouse #Johannesburg #South #Africa

Related Posts

Leave a Reply